“A Phase III, Randomized, Double-Blind, Controlled Study (PEMPHIX) to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Patients With Pemphigus Vulgaris”. SKIN The Journal of Cutaneous Medicine 4, no. 1 (January 28, 2020): S26. Accessed April 19, 2026. https://skin.dermsquared.com/skin/article/view/806.